9
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T23407 | surface antigen (208-215) [Hepatitis B Virus] | Others | |
The nucleocapsid of the hepatitis B virus is covered by an envelope of HBV surface antigen (HBsAg), which has the common, group-specific determinant a. The four major subtypes of HBsAg, adw, adr, ayw and ayr, are generat... | |||
T27527 | HBF-0259 | HBF 0259 | Antiviral |
HBF-0259 is an inhibitors of hepatitis B virus surface antigen (HBsAg) secretion with an EC50 of 11.3 μM and a CC50 value of >50 μM in HepG2.2.15 cells. HBF-0259 had a EC50 of approximately 1.5 microM in a secondary, HBV... | |||
TN4751 | Periglaucine B | HBV | |
Periglaucine B can inhibit hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. | |||
TN4750 | Periglaucine A | HBV | |
Periglaucine A inhibits hepatitis B virus (HBV) surface antigen (HBsAg) secretion in Hep G2.2.15 cells. | |||
T76528 | Hepatitis b virus pre-s region (120-145) | ||
Hepatitis B Virus Pre-S Region (120-145) is a preS2 peptide that effectively blocks the attachment of single-chain Fv fragment (scFv) or IgG to recombinant Hepatitis B surface antigen (r-HBsAg) [1]. | |||
T35771 | Destruxin B2 | ||
Destruxin B2 is a cyclic hexadepsipeptide mycotoxin that has been found in M. anisopliae and has antiviral, insecticidal, and phytotoxic activities.1,2,3 It inhibits secretion of hepatitis B virus surface antigen (HBsAg)... | |||
T79976 | Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside | HBV | |
Dihydrodehydrodiconiferyl alcohol 9-O-β-D-xylopyranoside serves as an anti-hepatitis B virus (anti-HBV) agent, effectively inhibiting the secretion of HBV surface antigen (HBsAg) and HBV e antigen (HBeAg) in the Hep G2.2... | |||
T76531 | HBV Seq2 aa:179-186 | ||
HBV Seq2 aa:179-186, a novel epitope located on the hepatitis B virus surface antigen, effectively serves as a motif for CTL response within the H-2b system following in vitro restimulation of primed T cells [1]. | |||
T69709 | GST-HG131 | ||
GST-HG131, a dihydrobenzopyridooxazepine (DBP) series compound, specifically inhibits hepatitis B virus (HBV) surface antigen. It demonstrates excellent HBV antigens inhibition, with EC50 values of 28.2 nM (HBsAg) and 16... |